Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.
NCT01562522 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2019-11-07
Summary
The purpose of the protocol, is to assess the feasibility of conducting a larger trial to evaluate the effect of a psychological intervention on the well-being of patients on luteinizing hormone-releasing hormone (LHRH) analogs in the treatment of prostate cancer and their partners.
Conditions
Interventions
- OTHER
-
Psychological counseling
Attendance at 7 group sessions, consisting of 5-6 couples, preceded by an intake consultation. Total intervention time: 16 weeks.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director Oncology · Ipsen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Living Well on Androgen Deprivation Therapy
NCT02108613 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
NCT03361969 ·Status: COMPLETED ·Phase: PHASE2
-
Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy
NCT03516110 ·Status: COMPLETED
-
A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer
NCT01383863 ·Status: COMPLETED
-
Hormone Therapy in Treating Patients With Advanced Prostate Cancer
NCT00003026 ·Status: COMPLETED ·Phase: PHASE3
-
Prostate Cancer - Patient Empowerment Program
NCT03660085 ·Status: COMPLETED ·Phase: NA
-
Prostate Nutrition and Exercise STudy (ProNEST)
NCT03173807 ·Status: WITHDRAWN ·Phase: NA
-
Prostatic Cancer Versus Androgen Deficiency
NCT02235142 ·Status: COMPLETED ·Phase: NA
-
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
NCT00161252 ·Status: WITHDRAWN
-
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
NCT06733350 ·Status: RECRUITING ·Phase: PHASE4
-
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
NCT00032006 ·Status: COMPLETED ·Phase: PHASE2
-
Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners
NCT00503646 ·Status: UNKNOWN ·Phase: NA
-
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
NCT02066961 ·Status: COMPLETED
-
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer
NCT02440802 ·Status: UNKNOWN
-
Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer
NCT02238366 ·Status: COMPLETED
-
Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223
NCT04995614 ·Status: COMPLETED
-
An Alternative to A Fixed Schedule In Management Of Prostate Cancer
NCT01056562 ·Status: COMPLETED
-
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
NCT01957436 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
NCT05100472 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
NCT00082732 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
NCT00955435 ·Status: UNKNOWN
-
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
NCT00571675 ·Status: COMPLETED ·Phase: PHASE2
-
Flavopiridol in Treating Patients With Recurrent Prostate Cancer
NCT00003256 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients
NCT03017313 ·Status: COMPLETED
-
PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC
NCT00313482 ·Status: TERMINATED ·Phase: PHASE2